Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation (Q35868819)

10 August 2017

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation (English)

1 reference

10 August 2017

0 references

0 references

0 references

0 references

1 reference

17

Andrea Natale

1 reference

10 August 2017

11

Johan Vijgen

1 reference

10 August 2017

Riccardo Cappato

1

1 reference

10 August 2017

Francis E Marchlinski

2

1 reference

10 August 2017

Stefan H Hohnloser

3

1 reference

10 August 2017

Gerald V Naccarelli

4

1 reference

10 August 2017

Jim Xiang

5

1 reference

10 August 2017

David J Wilber

6

1 reference

10 August 2017

Chang-Sheng Ma

7

1 reference

10 August 2017

Susanne Hess

8

1 reference

10 August 2017

Darryl S Wells

9

1 reference

10 August 2017

George Juang

10

1 reference

10 August 2017

Burkhard J Hügl

12

1 reference

10 August 2017

Richard Balasubramaniam

13

1 reference

10 August 2017

Christian De Chillou

14

1 reference

10 August 2017

D Wyn Davies

15

1 reference

10 August 2017

L Eugene Fields

16

1 reference

10 August 2017

VENTURE-AF Investigators

18

1 reference

10 August 2017

14 May 2015

1 reference

10 August 2017

European Heart Journal

1 reference

10 August 2017

36

1 reference

10 August 2017

1805-1811

1 reference

10 August 2017

28

1 reference

Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Periprocedural management of new oral anticoagulants in patients undergoing atrial fibrillation ablation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) P

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Complications of catheter ablation of atrial fibrillation: a systematic review

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: special considerations

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Current periprocedural management of ablation for atrial fibrillation in Europe: results of the European Heart Rhythm Association survey

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Catheter ablation of atrial fibrillation: the need for studies to assess the efficacy and safety of novel anticoagulants

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design:

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508487

Dabigatran in catheter ablation of atrial fibrillation: a call for a randomized control trial

14 November 2018

1 reference

12 December 2020

Complication rates of atrial fibrillation ablations: comparison of safety outcomes from real world to contemporary randomized control trials

1 reference

12 December 2020

Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation

1 reference

12 December 2020

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

1 reference

12 December 2020

Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance?

1 reference

12 December 2020

Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment

1 reference

12 December 2020

Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls

1 reference

12 December 2020

Identifiers

DOI

10.1093/EURHEARTJ/EHV177

1 reference

10 August 2017

1 reference

10 August 2017

1 reference